Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

SB-773812

Generic Name: SB-773812

Drug Type: Small Molecule

Chemical Formula: C_₂₅H_₂₆ClNO_₄S

CAS Number: 630407-66-8

Unique Ingredient Identifier: ZNP5SNF9FY

Overview

SB-773812 is under investigation in clinical trial NCT00259870 (SB-773812 Administered in Adults With Schizophrenia).

Background

SB-773812 is under investigation in clinical trial NCT00259870 (SB-773812 Administered in Adults With Schizophrenia).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812

Phase 1

Completed

Posted: 2006/12/15

Sponsor:GlaxoSmithKline

ID:NCT00411866

SPECT Study With SB-773812 In Schizophrenic Patients

Phase 1

Completed

Posted: 2005/12/23

Sponsor:GlaxoSmithKline

ID:NCT00269035

SB-773812 Administered In Adults With Schizophrenia

Phase 2

Completed

Posted: 2005/12/01

Sponsor:GlaxoSmithKline

ID:NCT00259870

In-Patient Study In Schizophrenic Patients

Phase 1

Completed

Posted: 2005/09/20

Sponsor:GlaxoSmithKline

ID:NCT00197093

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy